58 related articles for article (PubMed ID: 23547854)
1. Pregabalin abuse after past substance-seeking behavior.
Papazisis G; Garyfallos G; Sardeli C; Kouvelas D
Int J Clin Pharmacol Ther; 2013 May; 51(5):441-2. PubMed ID: 23547854
[TBL] [Abstract][Full Text] [Related]
2. Habitual alcohol seeking: modeling the transition from casual drinking to addiction.
Barker JM; Taylor JR
Neurosci Biobehav Rev; 2014 Nov; 47():281-94. PubMed ID: 25193245
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in pregabalin-seeking like behavior in a conditioned place preference paradigm.
Alsaab HO; Altowairqi E; Alzahrani N; Alzahrani R; Alshehri FS; Almalki AH; Alsanie WF; Gaber A; Alkhalifa T; Almalki A; Shah ZA; Althobaiti YS
Saudi Pharm J; 2020 Dec; 28(12):1749-1755. PubMed ID: 33424265
[TBL] [Abstract][Full Text] [Related]
4. Very high dose of pregabalin abuse: A case report.
Gupta M; Singh J; Udey B
Indian J Psychiatry; 2023 Sep; 65(9):979-980. PubMed ID: 37841555
[No Abstract] [Full Text] [Related]
5. Pregabalin's abuse potential: a mini review focusing on the pharmacological profile.
Papazisis G; Tzachanis D
Int J Clin Pharmacol Ther; 2014 Aug; 52(8):709-16. PubMed ID: 24849194
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin dependence: a case report.
Halaby A; Kassm SA; Naja WJ
Curr Drug Saf; 2015; 10(2):184-6. PubMed ID: 25336156
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin abuse among opiate addicted patients.
Grosshans M; Lemenager T; Vollmert C; Kaemmerer N; Schreiner R; Mutschler J; Wagner X; Kiefer F; Hermann D
Eur J Clin Pharmacol; 2013 Dec; 69(12):2021-5. PubMed ID: 23989299
[TBL] [Abstract][Full Text] [Related]
8. Misuse and abuse of pregabalin and gabapentin: cause for concern?
Schifano F
CNS Drugs; 2014 Jun; 28(6):491-6. PubMed ID: 24760436
[TBL] [Abstract][Full Text] [Related]
9. Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers.
Baird CR; Fox P; Colvin LA
Eur Addict Res; 2014; 20(3):115-8. PubMed ID: 24192603
[TBL] [Abstract][Full Text] [Related]
10. [Pregabalin can cause addiction and withdrawal symptoms].
Nordgaard J; Jürgens G
Ugeskr Laeger; 2015 Jan; 177(2A):38-9. PubMed ID: 25612958
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of alcohol dependence: rational and arguable approaches].
Sivolap IuP
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5 Pt 2):53-6. PubMed ID: 24988976
[TBL] [Abstract][Full Text] [Related]
12. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
[TBL] [Abstract][Full Text] [Related]
13. Abuse and Misuse of Pregabalin and Gabapentin.
Evoy KE; Morrison MD; Saklad SR
Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
[TBL] [Abstract][Full Text] [Related]
14. [Pregabalin and risk of addiction: A new care issue?].
Roche S; Blaise M
Encephale; 2020 Oct; 46(5):372-381. PubMed ID: 32471706
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history.
Driot D; Chicoulaa B; Jouanjus E; Dupouy J; Oustric S; Lapeyre-Mestre M
Therapie; 2016 Dec; 71(6):575-578. PubMed ID: 27473599
[TBL] [Abstract][Full Text] [Related]
16. [On the risk of dependence on gabapentinoids].
Bonnet U; Scherbaum N
Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
[TBL] [Abstract][Full Text] [Related]
17. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
Chiappini S; Schifano F
CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Safety Signal for the Abuse Potential of Pregabalin and Gabapentin Using the FAERS Database and Big Data Search Analytics.
Papazisis G; Spachos D; Siafis S; Pandria N; Deligianni E; Tsakiridis I; Goulas A
Front Psychiatry; 2021; 12():640264. PubMed ID: 34093263
[No Abstract] [Full Text] [Related]
19. Lack of correlation between the activity of the mesolimbic dopaminergic system and the rewarding properties of pregabalin in mouse.
Coutens B; Mouledous L; Stella M; Rampon C; Lapeyre-Mestre M; Roussin A; Guiard BP; Jouanjus E
Psychopharmacology (Berl); 2019 Jul; 236(7):2069-2082. PubMed ID: 30879119
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.
Al-Husseini A; Wazaify M; Van Hout MC
Int J Ment Health Addict; 2018; 16(3):642-654. PubMed ID: 29904327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
